InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Samuelson Doug. Officer active across 2 companies, notably GENELUX CORP. Cumulatively, 4 disclosures have been published. Split: 1 buy · 1 sell. Total volume traded: €32k. History available since 17 February 2023. The latest transaction was disclosed on 8 October 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Samuelson Doug is a declarant linked to Kairos Pharma, LTD. and GENELUX CORP, where he is Chief Financial Officer. He has 4 filings in total, and among the sampled recent filings, the buy amount is EUR 3582 and the sell amount is EUR 28302, over the period from 2023-05-02 to 2025-11-26. The modal transaction nature is Attribution.